MACMILLAN CANCER SUPPORT

Active London
1,697 employees website.com
Healthcare and wellbeing
M

MACMILLAN CANCER SUPPORT

Founded 30 Jun 1989 Active London, England 1,697 employees website.com
Healthcare and wellbeing

Previous Company Names

MACMILLAN CANCER RELIEF 20 Apr 1997 — 29 Jun 2006
CANCER RELIEF MACMILLAN FUND 30 Jun 1989 — 20 Apr 1997
Accounts Submitted 16 Sept 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 18 Jul 2025 Next due 31 Jul 2026 3 months remaining
Net assets £39M £21M 2024 year on year
Total assets £188M £13M 2024 year on year
Total Liabilities £149M £34M 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

3rd Floor Bronze Building, The Forge 105 Sumner Street London SE1 9HZ England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for MACMILLAN CANCER SUPPORT (02400969), an active healthcare and wellbeing company based in London, England. Incorporated 30 Jun 1989. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£5.52M

Decreased by £4.21M (-43%)

Net Assets

£39.27M

Increased by £21.12M (+116%)

Total Liabilities

£148.80M

Decreased by £33.93M (-19%)

Turnover

£245.55M

Increased by £13.01M (+6%)

Employees

1697

Decreased by 217 (-11%)

Debt Ratio

79%

Decreased by 12 (-13%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 8

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

MACMILLAN CANCER SUPPORT Current Company

Charges

Charges

1 satisfied

Properties

Properties

3 freehold 28 leasehold 31 total
AddressTenurePrice PaidDate Added
Third Floor, Bronze Building, 105 Sumner Street, London (SE1 9HZ) SOUTHWARK
Leasehold-16 Apr 2024
25 Westcott, Trevanson Road, Wadebridge, (PL27 7HG) CORNWALL
Freehold-26 Sept 2019
Unit U2590 Basement Storage Area 9, Camelford House, 89 Albert Embankment, London (SE1 7UQ) LAMBETH
Leasehold-5 Sept 2019
Eighth Floor Offices, Tower Wing, 89 Albert Embankment, London (SE1 7TP) LAMBETH
Leasehold-5 Sept 2019
Unit U2520 Basement Storage Area 2, Camelford House, 89 Albert Embankment, London (SE1 7UQ) LAMBETH
Leasehold-5 Sept 2019
Third Floor, Bronze Building, 105 Sumner Street, London (SE1 9HZ)
Leasehold
Added 16 Apr 2024
District SOUTHWARK
25 Westcott, Trevanson Road, Wadebridge, (PL27 7HG)
Freehold
Added 26 Sept 2019
District CORNWALL
Unit U2590 Basement Storage Area 9, Camelford House, 89 Albert Embankment, London (SE1 7UQ)
Leasehold
Added 5 Sept 2019
District LAMBETH
Eighth Floor Offices, Tower Wing, 89 Albert Embankment, London (SE1 7TP)
Leasehold
Added 5 Sept 2019
District LAMBETH
Unit U2520 Basement Storage Area 2, Camelford House, 89 Albert Embankment, London (SE1 7UQ)
Leasehold
Added 5 Sept 2019
District LAMBETH

Documents

Company Filings

DateCategoryDescriptionDocument
9 Mar 2026OfficersTermination of Iain Charles Andrew Cornish as director on 2026-03-05
9 Mar 2026OfficersTermination of Richard Andrew Murley as director on 2026-03-05
9 Mar 2026OfficersTermination of Jagjit Singh Ahluwalia as director on 2026-03-05
16 Dec 2025OfficersAppointment of Ms Anne-Francoise Michele Nesmes as director on 2025-12-10
28 Nov 2025OfficersChange to director Dr Anas Nader on 2025-06-01
9 Mar 2026 Officers

Termination of Iain Charles Andrew Cornish as director on 2026-03-05

9 Mar 2026 Officers

Termination of Richard Andrew Murley as director on 2026-03-05

9 Mar 2026 Officers

Termination of Jagjit Singh Ahluwalia as director on 2026-03-05

16 Dec 2025 Officers

Appointment of Ms Anne-Francoise Michele Nesmes as director on 2025-12-10

28 Nov 2025 Officers

Change to director Dr Anas Nader on 2025-06-01

Recent Activity

Latest Activity

Termination of Iain Charles Andrew Cornish as director on 2026-03-05

1 months ago on 9 Mar 2026

Termination of Richard Andrew Murley as director on 2026-03-05

1 months ago on 9 Mar 2026

Termination of Jagjit Singh Ahluwalia as director on 2026-03-05

1 months ago on 9 Mar 2026

Appointment of Ms Anne-Francoise Michele Nesmes as director on 2025-12-10

4 months ago on 16 Dec 2025

Change to director Dr Anas Nader on 2025-06-01

4 months ago on 28 Nov 2025